Woldu SL - Search Results

1

Woldu SL, Amatruda JF, Bagrodia A. Woldu SL, et al. Curr Opin Urol. 2017 Jan;27(1):41-47. doi: 10.1097/MOU.0000000000000347. Curr Opin Urol. 2017. PMID: 27584029 Free PMC article. Review.

2

Utilization of the Robotic Surgical Platform for Radical Nephrectomy: A National Comparison of Trends for Open, Laparoscopic and Robotic Approaches.

Weinberg AC, Whalen MJ, Paulucci DJ, Woldu S, Deibert CM, Korets R, Badani KK. Weinberg AC, et al. Urol Pract. 2016 May;3(3):187-194. doi: 10.1016/j.urpr.2015.07.007. Epub 2016 Feb 22. Urol Pract. 2016. PMID: 37592502

3

Use of Partial Nephrectomy after Acquisition of a Surgical Robot: A Population Based Study.

Weinberg AC, Wright JD, Whalen MJ, Paulucci DJ, Woldu SL, Berger SA, Deibert CM, Korets R, Hershman DL, Neugut AI, Badani KK. Weinberg AC, et al. Among authors: woldu sl. Urol Pract. 2016 Nov;3(6):430-436. doi: 10.1016/j.urpr.2015.10.001. Epub 2016 Jul 21. Urol Pract. 2016. PMID: 37592577

4

Guideline of guidelines: non-muscle-invasive bladder cancer.

Woldu SL, Bagrodia A, Lotan Y. Woldu SL, et al. BJU Int. 2017 Mar;119(3):371-380. doi: 10.1111/bju.13760. Epub 2017 Jan 24. BJU Int. 2017. PMID: 28058776 Free PMC article. Review.

5

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer.

Aydin AM, Woldu SL, Hutchinson RC, Boegemann M, Bagrodia A, Lotan Y, Margulis V, Krabbe LM. Aydin AM, et al. Among authors: woldu sl. Onco Targets Ther. 2017 Mar 9;10:1487-1502. doi: 10.2147/OTT.S109453. eCollection 2017. Onco Targets Ther. 2017. PMID: 28331342 Free PMC article. Review.

6

Impact of hospital case volume on testicular cancer outcomes and practice patterns.

Woldu SL, Matulay JT, Clinton TN, Singla N, Krabbe LM, Hutchinson RC, Sagalowsky A, Lotan Y, Margulis V, Bagrodia A. Woldu SL, et al. Urol Oncol. 2018 Jan;36(1):14.e7-14.e15. doi: 10.1016/j.urolonc.2017.08.024. Epub 2017 Sep 19. Urol Oncol. 2018. PMID: 28935185

7

Re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70.

Bagrodia A, Woldu S, Penson DF, Kutikov A, Kaffenberger SD. Bagrodia A, et al. Eur Urol. 2018 Apr;73(4):e98-e99. doi: 10.1016/j.eururo.2017.09.019. Epub 2017 Oct 9. Eur Urol. 2018. PMID: 29032846 No abstract available.

8

Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses.

Woldu SL, Aydin AM, Rao AV, Hutchinson RC, Singla N, Clinton TN, Krabbe LM, Passoni NM, Raj GV, Miller DS, Amatruda JF, Sagalowsky AI, Lotan Y, Arriaga Y, Margulis V, Bagrodia A. Woldu SL, et al. Urology. 2018 Feb;112:103-111. doi: 10.1016/j.urology.2017.08.059. Epub 2017 Dec 6. Urology. 2018. PMID: 29079210

9

Reply.

Woldu SL, Bagrodia A, Moore JA, Arriaga Y. Woldu SL, et al. Urology. 2018 Feb;112:111. doi: 10.1016/j.urology.2017.08.061. Epub 2017 Dec 6. Urology. 2018. PMID: 29198421 No abstract available.

10

Tissue-based biomarkers in prostate cancer.

Clinton TN, Bagrodia A, Lotan Y, Margulis V, Raj GV, Woldu SL. Clinton TN, et al. Among authors: woldu sl. Expert Rev Precis Med Drug Dev. 2017;2(5):249-260. doi: 10.1080/23808993.2017.1372687. Epub 2017 Sep 5. Expert Rev Precis Med Drug Dev. 2017. PMID: 29226251 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page